BullishWhales · Analysts · Analyst Profile
Analyst rating accuracy & track record
Rachel Vatnsdal does not yet have enough resolved 12-month calls to carry a published score. Check back as their ratings mature.
Ratings & price targets
| Stock | Rating | Price target | Rated | 12-mo vs sector | PT hit |
|---|---|---|---|---|---|
 TWSTTwist Bioscience Corp | Sell | $33.00 | May 2025 | −72.3% | Hit |
 RGENRepligen Corporation | Buy | $190.00 | Apr 2025 | −21.5% | Miss |
| TWSTTwist Bioscience Corp | Sell | $40.00 | Feb 2025 | +17.3% | Hit |
 ADPTAdaptive Biotechnologies Corp | Buy | $6.00 | Aug 2024 | +160.4% | Hit |
| ADPTAdaptive Biotechnologies Corp | Buy | $5.00 | May 2024 | +165.3% | Hit |
| ADPTAdaptive Biotechnologies Corp | Buy | $8.00 | Feb 2024 | +115.3% | Hit |
Go to
Browse the full analyst leaderboardHow analyst accuracy is scored
Every score, Win %, PT Hit % and rank is an estimate Bullish Whales calculates from its own data and may not be 100% accurate or complete. Returns are measured in excess of each rated stock's own sector over the 12 months after each call. Past performance does not guarantee future results, and nothing here is a recommendation to buy or sell any security.